DrugNews Updated Legal News: Pradaxa Lawsuits Rise for January

• 

Anyone affected by internal bleeding after taking Pradaxa is encouraged to visit DrugNews.net or speak with a lawyer about their legal options.

New York, NY (PRWEB) January 18, 2014

The DrugNews prescription drug safety center has added new information to its legal news resource for patients who’ve taken the blood thinner Pradaxa. Recent court records show the number of lawsuits alleging the drug caused internal bleeding have grown in the past month*.

The news comes as the FDA recently ordered a new study into the safety of Pradaxa**.

DrugNews is a free consumer resource designed to give those taking popular prescription drugs the latest safety alerts, research, litigation news and recalls. Patients can avoid dangerous drugs, see if others are experiencing similar side effects and decide if they need legal advice.

Pradaxa is a blood thinner that was approved by the FDA in 2010 to prevent blood clots and strokes in patients with atrial fibrillation. Experts disagree, however, about whether it increases risks of internal bleeding.

The FDA had previously stated Pradaxa is as safe as traditional blood thinner warfarin***. The Institute for Safe Medication Practices, however, warned that Pradaxa bleeding may be almost 5 times as likely to cause death****. A recent study also suggested patients taking blood thinners like Pradaxa may be 55% more likely to suffer internal bleeding*****.

The FDA recently announced it will conduct a new study to measure the rates of bleeding and blood clot events from Pradaxa and warfarin among those with atrial fibrillation**.

A number of patients have already filed a Pradaxa lawsuit alleging internal bleeding, leading to the consolidation of claims to a special federal multidistrict litigation court. The case is formally known as MDL No. 2385, IN RE: Pradaxa Product Liability Litigation, Southern District of Illinois.

Now, DrugNews has learned that the most recent court records show the number of cases filed increased over 6% in the past month, from 1,936 on December 16th to 2,057 on January 15th*.

Anyone affected by internal bleeding after taking Pradaxa is encouraged to visit DrugNews.net or speak with a lawyer about their legal options. However, due to the specialized nature of federal drug injury cases, DrugNews only recommends lawyers who have already handled Pradaxa lawsuits.

Visit http://www.DrugNews.net today for more information on the research, side effects and litigation news related to Pradaxa and other drugs, or to speak with a lawyer.

*Judicial Panel on Multidistrict Litigation, 1/15/14; jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets_By_District-January-15-2014.pdf
**Forbes, 1/3/14; forbes.com/sites/larryhusten/2014/01/03/fda-plans-new-safety-assessment-of-dabigatran-pradaxa/
***FDA, 11/2/12; http://www.fda.gov/Drugs/DrugSafety/ucm326580.htm
****Institute for Safe Medication Practices, 1/9/13; ismp.org/quarterwatch/pdfs/2012Q2.pdf
*****Gastroenterology, July 2013; gastrojournal.org/article/S0016-5085(13)00290-4/fulltext

PDF Print